Patent details

Basic Information

Publication number:

EP2226085

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP101530772

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Anti-angiogenic compositions and methods of use

French Title of Invention:

Compositions anti-angiogéniques et leurs procédés d'utilisation

German Title of Invention:

Anti-Angiogene Mittel und Verfahren zu deren Verwendung

SPC Number:

92423
92422

Dates

Filing date:

19/07/1994

Grant date:

27/11/2013

EP Publication Date:

27/11/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/09/2010

EP B1 Publication Date:

27/11/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

19/07/2014

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/07/1994

 

 

Name:

Angiotech Pharmaceuticals Inc.

Address:

1618 Station Street, Vancouver, British Columbia V6A 1B6, Canada (CA)

Name:

UNIVERSITY OF BRITISH COLUMBIA

Address:

University Industry Liaison Office 103-6190 Agronomy Road, Vancouver, BC V6T 1Z3, Canada (CA)

Agent

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

22/01/2014

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Arsenault Larry A.

Address:

Canada (CA)

2

Name:

Machan Lindsay S.

Address:

Canada (CA)

3

Name:

Hunter William L.

Address:

Canada (CA)

Priority

Priority Number:

94536

Priority Date:

19/07/1993

Priority Country:

United States (US)

Classification

Main IPC Class:

A61L 31/10;

Filing date	Document type	Number of pages